-+ 0.00%
-+ 0.00%
-+ 0.00%

Lantern Pharma issues unregistered warrants in private placement for up to 3,669,725 shares

PUBT·09/30/2026 20:01:27
Listen to the news
Lantern Pharma issues unregistered warrants in private placement for up to 3,669,725 shares
  • Lantern Pharma closed a concurrent private placement of unregistered warrants to buy up to 3,669,725 common shares.
  • Warrants carry a $1.09 exercise price; exercise starts after stockholder approval of the underlying share issuance.
  • Potential additional gross proceeds total about $4 million if the warrants are fully exercised for cash.
  • Warrants expire five years after stockholder approval; no assurance any warrants will be exercised.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantern Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260930166248) on September 30, 2026, and is solely responsible for the information contained therein.